Physician Search

Consuelo Wilkins, MD, MSCI, Senior Vice President for Health Equity and Inclusive Excellence for Vanderbilt University Medical Center (VUMC) and Senior Associate Dean for Health Equity and Inclusive Excellence for Vanderbilt University School of Medicine, always knew she wanted to be a physician. "Health equity was built into everything I did, even if I didn’t know it or recognize it at the time," Wilkins said. "I have always learned and believed that people are the same — everyone deserves to be healthy, and everyone should have the best opportunities to take care of themselves and their families." Click below to learn more about health equity initiatives.

https://momentum.vicc.org/2021/09/everyone-deserves-to-be-healthy/

Vanderbilt was the lead site for an NIH-funded, phase 2, multicenter influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant (HCT) recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population. Natasha Halasa, MD, MPH and colleagues recently published in the New England Journal of Medicine, that two doses of high-dose trivalent flu vaccine resulted in higher amounts of influenza-specific antibodies than two doses of standard dose quadrivalent vaccine.

https://news.vumc.org/2023/03/02/high-dose-flu-vaccine-beneficial-for-pediatric-stem-cell-transplant-patients/

Filter By:
Search by Keyword:

Displaying 71 - 80 of 323

A Pivotal, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System™ Kit, in Subjects with Hypertension

Disease Sites: Not Available

Phase: III

Investigator: Not Available

NCTID: NCT02910414

Protocol No: CRE-INT0003

TAVR Low Risk & CAS - Transcatheter Aortic Valve Replacement (TAVR) in Patients with the Medtronic Transcatheter Aortic Valve Replacement System (TAVR) in Patients at Low Risk for Surgical Aortic Valve Replacement (SAVR) Continued Access Trial

Disease Sites: Not Available

Phase: IV

Investigator: Goel, Kashish

NCTID: NCT02701283

Protocol No: CRE-INT0008

Occluflex - Prospective randomized multi-center controlled clinical investigation comparing PFO outcomes of the Occlutech Figulla Flex II PFO Occluder to standard of care PFO occlusion.

Disease Sites: Not Available

Phase: II/III

Investigator: Piana, Robert

NCTID: NCT05069558

Protocol No: CRE-INT0005

Genetics of Appendix Cancer: The GAP Study

Colon

Disease Sites: Colon

Phase: N/A

Investigator: Holowatyj, Andreana

NCTID: NCT05734430

Protocol No: VICCGI2280

The RADIANCE-HTN; Study A study of the ReCor Medical Paradise System in Clinical Hypertension

Disease Sites: Not Available

Phase: III

Investigator: Fong, Pete

NCTID: NCT02649426

Protocol No: CRE-INT0001

OPTION: Comparison of Anticoagulation with Left Atrial Appendage Closure after AF Ablation

Disease Sites: Not Available

Phase:

Investigator: Kanagasundram, Arvindh

NCTID: NCT03795298

Protocol No: CRE-ARR0004

CHAMPION -AF - WATCHMAN FLX versus NOAC for Embolic Protection in the Management of Patients with Non-Valvular Atrial Fibrillation

Disease Sites: Not Available

Phase:

Investigator: Ellis, Christopher

NCTID: NCT03795298

Protocol No: CRE-ARR0006

Head and Neck Tumor Tissue Repository and Clinical Database

Head/Neck

Disease Sites: Head/Neck

Phase: N/A

Investigator: Rosenthal, Eben

NCTID: NCT00898638

Protocol No: VICCHN0356

Renal Tumors Classification, Biology, and Banking Study

Multiple Cancer Types

Disease Sites: Pediatrics, Wilms / Other Kidney (Pediatrics)

Phase: N/A

Investigator: Benedetti, Daniel

NCTID: NCT00898365

Protocol No: COGAREN03B2

Storage and Research Use of Human Biospecimens from Melanoma Patients and Clinical Testing for the Assignment of Therapy

Melanoma

Disease Sites: Melanoma

Phase: N/A

Investigator: Johnson, Douglas

NCTID: NCT01205815

Protocol No: VICCMEL09109